CH670451A5 - - Google Patents

Download PDF

Info

Publication number
CH670451A5
CH670451A5 CH4672/86A CH467286A CH670451A5 CH 670451 A5 CH670451 A5 CH 670451A5 CH 4672/86 A CH4672/86 A CH 4672/86A CH 467286 A CH467286 A CH 467286A CH 670451 A5 CH670451 A5 CH 670451A5
Authority
CH
Switzerland
Prior art keywords
amino acid
aliphatic
polar
atoms
toxic peptide
Prior art date
Application number
CH4672/86A
Other languages
German (de)
English (en)
Inventor
Hans Marquardt
George J Todaro
Daniel R Twardzik
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of CH670451A5 publication Critical patent/CH670451A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH4672/86A 1985-11-22 1986-11-21 CH670451A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/801,019 US4731439A (en) 1985-11-22 1985-11-22 Snake venom growth arresting peptide

Publications (1)

Publication Number Publication Date
CH670451A5 true CH670451A5 (es) 1989-06-15

Family

ID=25179974

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4672/86A CH670451A5 (es) 1985-11-22 1986-11-21

Country Status (20)

Country Link
US (1) US4731439A (es)
KR (1) KR900006575B1 (es)
CN (1) CN86108593A (es)
AU (3) AU6556386A (es)
BE (1) BE905790A (es)
CH (1) CH670451A5 (es)
DE (1) DE3639796A1 (es)
DK (1) DK560986A (es)
ES (1) ES2002915A6 (es)
FI (1) FI864715A (es)
FR (1) FR2590576A1 (es)
GB (1) GB2185023B (es)
GR (1) GR862788B (es)
IT (1) IT1207580B (es)
LU (1) LU86683A1 (es)
NL (1) NL8602939A (es)
PT (1) PT83790B (es)
SE (1) SE8604991L (es)
YU (1) YU199586A (es)
ZA (1) ZA868849B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015072A1 (en) * 1989-06-07 1990-12-13 Genentech, Inc. Platelet aggregation inhibitors and related molecules
WO1991001740A1 (en) * 1989-08-05 1991-02-21 Varánusz Gm Process for producing pharmacosmetics
US5232911A (en) * 1990-01-03 1993-08-03 Ventech Research Inc. Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
DE4433890C2 (de) * 1994-09-22 1999-02-18 Deutsches Krebsforsch Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein
SG129211A1 (en) * 1997-11-06 2007-02-26 Univ Singapore Therapeutic molecules
BR0101088A (pt) * 2001-03-19 2003-03-18 Biolab Sanus Farmaceutica Ltda Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.
BRPI0501037B8 (pt) * 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
US20060234934A1 (en) * 2005-04-15 2006-10-19 Kilmon Joseph A Composition and Method for Selective Cytostasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4220722A (en) * 1978-02-10 1980-09-02 Syva Company Method for conjugating to polyamino compounds employing haloacyl groups and compositions prepared thereby
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
US4500637A (en) * 1982-07-19 1985-02-19 The United States Of America As Represented By The Department Of Health And Human Services Prevention of graft versus host disease following bone marrow transplantation

Also Published As

Publication number Publication date
GB8627710D0 (en) 1986-12-17
ZA868849B (en) 1987-07-29
ES2002915A6 (es) 1988-10-01
SE8604991L (sv) 1987-05-23
FR2590576A1 (fr) 1987-05-29
IT8622425A0 (it) 1986-11-21
FI864715A0 (fi) 1986-11-19
GR862788B (en) 1987-03-26
DE3639796A1 (de) 1987-07-09
US4731439A (en) 1988-03-15
CN86108593A (zh) 1987-09-30
GB2185023A (en) 1987-07-08
NL8602939A (nl) 1987-06-16
AU6560986A (en) 1987-05-28
GB2185023B (en) 1990-08-29
BE905790A (fr) 1987-05-19
KR900006575B1 (ko) 1990-09-13
DK560986D0 (da) 1986-11-21
SE8604991D0 (sv) 1986-11-21
PT83790A (en) 1986-12-01
KR870005014A (ko) 1987-06-04
FI864715A (fi) 1987-05-23
AU6667590A (en) 1991-03-28
PT83790B (pt) 1989-09-14
DK560986A (da) 1987-05-23
YU199586A (en) 1988-06-30
IT1207580B (it) 1989-05-25
AU6556386A (en) 1987-05-28
LU86683A1 (fr) 1987-06-26

Similar Documents

Publication Publication Date Title
EP0471701B1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung
DE69432629T2 (de) Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
DE69006306T2 (de) Synthetische peptide des konjugates von ubiquitin und histon h2a.
DE69017753T3 (de) Tumor-Nekrosefaktor-Bindungsprotein II, seine Reinigung und spezifische Antikörper
DE3689191T2 (de) Gereinigtes protein mit angiogenischer wirkung und dessen herstellung.
DE69028671T2 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
EP0021152B1 (de) Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung
DE102005029845B4 (de) Verfahren zur Diagnose von rheumatischen Erkrankungen
DE69126568T2 (de) Neues physiologisch aktives Schweinepeptid (CNP-53)
DE68925199T2 (de) Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke
WO1999015651A1 (de) Synthetische polypeptide zur diagnose und therapie von prionerkrankungen
Huang et al. RF-amide peptides isolated from the midgut of the corn earworm, Helicoverpa zea, resemble pancreatic polypeptide
CHRISTOFIDES et al. Distribution of PHI in the rat brain
CH670451A5 (es)
DE68911498T2 (de) Polypeptide, isoliert aus dem Gift von Hololena curta.
EP0298210B1 (de) Verfahren zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten und Mittel zu dessen Durchführung
DE60124915T2 (de) Synthetische peptide gegen neurologische krankheiten
DE60318749T2 (de) Paralytisches peptid von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten
DE60112424T2 (de) Protonen-abhängiges na+-kanal hemmendes polypeptid
DE102004051014A1 (de) Chemisch modifizierte Peptidanaloga
DE3781745T2 (de) Antikoerper zur verwendung fuer die bestimmung von menschlichem glycoalbumin.
DE3645095C2 (de) Antikörper
DE69735760T2 (de) Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung
DE69813620T2 (de) Verwendung von citrullin enthaltenden peptiden, die von filaggrin abstammen, zur behandlung von autoimmunkrankheiten
WO1994010297A1 (de) Verfahren zur herstellung hochreiner humaner gad-1- und gad-2-proteine

Legal Events

Date Code Title Description
PL Patent ceased